State Street Corp Adma Biologics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, State Street Corp holds 14,870,747 shares of ADMA stock, worth $253 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,870,747

Previous 13,004,993 14.35%

Holding current value

$253 Million

Previous $260 Million 1.9%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$15.62 - $22.62 $29.1 Million - $42.2 Million	1,865,754 Added 14.35%	14,870,747 $255 Million
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $55.4 Million - $99 Million	4,945,063 Added 61.35%	13,004,993 $260 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $14.9 Million - $27.9 Million	-2,493,423 Reduced 23.63%	8,059,930 $90.1 Million
Q1 2024 May 15, 2024	BUY	$4.4 - $6.74 $4.71 Million - $7.21 Million	1,069,763 Added 11.28%	10,553,353 $69.7 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $364,511 - $534,932	-118,348 Reduced 1.23%	9,483,590 $42.9 Million
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $3.16 Million - $4.2 Million	-911,965 Reduced 8.67%	9,601,938 $34.4 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $7.72 Million - $10.4 Million	-2,474,686 Reduced 19.05%	10,513,903 $38.8 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $5.96 Million - $7.67 Million	1,981,380 Added 18.0%	12,988,589 $43 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $3.91 Million - $6.15 Million	1,583,787 Added 16.81%	11,007,209 $42.7 Million
Q3 2022 Nov 15, 2022	BUY	$2.03 - $2.86 $13.1 Million - $18.5 Million	6,459,197 Added 217.91%	9,423,422 $22.9 Million
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $3.33 Million - $5.13 Million	2,330,710 Added 367.9%	2,964,225 $5.87 Million
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $280,666 - $401,265	219,271 Added 52.93%	633,515 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$1.13 - $1.65 $5,762 - $8,415	5,100 Added 1.25%	414,244 $468,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $902,054 - $1.24 Million	-597,387 Reduced 59.35%	409,144 $655,000
Q1 2021 May 17, 2021	SELL	$1.67 - $2.95 $134,682 - $237,911	-80,648 Reduced 7.42%	1,006,531 $1.77 Million
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $182,926 - $260,162	-101,626 Reduced 8.55%	1,087,179 $2.12 Million
Q3 2020 Nov 10, 2020	SELL	$2.04 - $3.74 $94,358 - $172,989	-46,254 Reduced 3.75%	1,188,805 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $103,050 - $140,098	42,583 Added 3.57%	1,235,059 $3.62 Million
Q1 2020 May 11, 2020	BUY	$1.5 - $4.59 $1.79 Million - $5.47 Million	1,192,476 New	1,192,476 $3.43 Million

Others Institutions Holding ADMA

# of Institutions

339

Shares Held

182M

Call Options Held

1.72M

Put Options Held

846K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.34B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Adma Biologics, Inc. Transaction History